U.S., March 5 -- An application to own the trademark for 'SETEVRI' has been filed on Jun. 03, 2024.
Owner(s):
DAIICHI SANKYO COMPANY, LIMITED; 3-5-1, Nihonbashi Honcho,, Chuo-ku Tokyo 103-8426, Japan
Goods and/or Services:
For: Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, pseudoxanthoma, systemic lupus erythematosus, cardiovascular diseases, kidney diseases, Netherton syndrome.
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) IN
https://eog-tmng.uspto.gov/#/issueDate=2025-03-04&serialNumber=79400277
Disclaimer: Curated by HT Syndication....